Optical Coherence Tomography - Rescan During Dissection of Macular Membranes
NCT ID: NCT02748421
Last Updated: 2016-04-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2016-05-31
2017-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optical Coherence Tomography in Gas-filled Eyes
NCT01266746
Optical Coherence Tomography-based Positioning for Macular Hole Surgery
NCT02650739
Vitrectomy With Internal Limiting Membrane Peeling for Myopic Traction Maculopathy
NCT04278079
Internal Limiting Membrane Peeling on Retinal Displacement
NCT04655781
Pneumatic Retinopexy Versus Vitrectomy With Gas for Retinal Detachment Due to Myopic Macular Hole
NCT00485199
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Materials and methods The investigators will evaluate 30 patients with changes in macular membranes with surgical removal of indication from the Retina and Vitreous outpatient sector of Unifesp - Paulista School of Medicine. The patients will be classified according to the diseases in the following groups: Macular Hole, Epiretinal Membrane, Traction Syndrome vitreomacular, and proliferative vitreoretinopathy of Retinal Detachment. Everyone will be informed about the risks and benefits of the study and sign an informed consent form. In the preoperative evaluation a complete ophthalmologic examination with complementary tests such as angiography and optical coherence tomography will be done.
Patients will undergo retinal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS. The team of surgeons will answer the questionnaire on the surgical difficulty regarding the identification and removal of macular membranes.
All patients will be assessed at 1, 7, 15, 30, 60 and 90 and 180 days after surgery, including the following tests:
* Measurement of visual acuity with best correction
* Previous Biomicroscopy
* Indirect Funduscopy
* tonometry
* Optical coherence tomography (OCT)
* Retinography Surgeries and procedures of the study groups will be conducted by the same team of surgeons and all surgeries and procedures will be carried out in IPEPO - Paulista Institute of Studies and Research in Ophthalmology / Vision Institute.
For each type of retinal disease, there will be a control group and a group OCT as detailed below: 1 - GROUP CONTROL The control group will undergo retinal surgery with conventional microscope without coupled OCT. This group will have its filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty regarding the identification and removal of macular membranes.
2 -GROUP OCT / RESCAN In the group microscope coupled to OCT, patients will undergo retinal surgery using the Lumera Microscope WITH RESCAN OCT - ZEISS and have their filmed and documented surgery. The team of surgeons will answer the questionnaire on the surgical difficulty regarding the identification and removal of macular membranes.
Statistical methodology All information will be presented by mean and standard deviation for the quantitative variables and absolute frequency (n) and relative (%) for qualitative variables.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Lumera Microscope with OCT RESCAN
in the group microscope coupled to OCT, patients will undergo retinal surgery using the Lumera microscope with Rescan OCT Zeiss
Lumera Microscope with OCT RESCAN
macular membrane dissection with OCT RESCAN
Conventional Microscope
control group without OCT RESCAN
Conventional Microscope
macular membrane dissection without OCT RESCAN
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Lumera Microscope with OCT RESCAN
macular membrane dissection with OCT RESCAN
Conventional Microscope
macular membrane dissection without OCT RESCAN
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of both sexes
* 1 diagnostics of the diseases Macular Hole,Epiretinal membrane,Traction Syndrome vitreomacular, vitreoretinopathy Proliferative Retina Detachment.
* Indication of vitreoretinal surgery
Exclusion Criteria
* Better visual acuity than or equal to 20/60.
* Any previous infection affecting any eye structure. transport costs and feeding of patients will be the responsibility of the researchers.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Instituto Paulista de Estudos e Pesquisa em Oftalmologia
OTHER
Federal University of São Paulo
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Michel Eid Farah
Michel Eid Farah
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michel Farah, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Federal University of São Paulo UNIFESP
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
50991615.6.0000.5505
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.